Press Conferences

Progress in Oncology

  • 18 May 2009
    Progress in Oncology

    Media information: Progress in Oncology

    News/ Information: New clinical data on lead oncology compounds presented at ASCO 2009: Oncology experts about results of the LUX-Lung study programme in lung cancer.
    Website:

    Boehringer Ingelheim in oncology: Update from ASCO

Congress Overview

News & Information

Speakers

Speakers Background information for medical media outside the US only
Prof. James Spicer
Senior Lecturer, Cancer Studies Division, King’s College London, and Consultant in Medical Oncology, Guy’s and St. Thomas’ Foundation Hospital NHS Trust, London, UK
Prof. James Spicer

Dr. James Spicer is Senior Lecturer in the Cancer Studies Division of King’s College London, and Honorary Consultant in Medical Oncology at Guy’s and St Thomas’ Foundation Hospital NHS Trust.

Dr Rolf Kaiser
International Medical Project Leader for Phase I–III studies in Oncology, Boehringer Ingelheim, Biberach, Germany
Dr Rolf Kaiser

Dr. Kaiser has received several awards for teaching and research during his career, including the Antiemetic Research Award from the Multinational Association of Supportive Care in Cancer (MASCC) in 2003 for his work in exploring the role of pharmacogenetics in emesis. His research has been extensively published in a range of leading international peer-reviewed journals, including the Journal of Clinical Oncology and The Lancet Oncology.

Images

Images & Videos
Videos
Images from Progress in Oncology
  • A tumor needs oxigen and nutrition to grow
    A tumor needs oxigen and nutrition to grow
  • Angiogenesis: Vessels invading the tumor transport oxigen and nutrition
    Angiogenesis: Vessels invading the tumor transport oxigen and nutrition
  • Angiogenesis Inhibition: Vessels degenerate or withdraw from tumor
    Angiogenesis Inhibition: Vessels degenerate or withdraw from tumor
  • Signal transduction: a ligand binds to a growth factor receptor and initiates growth signalling cascade
    Signal transduction: a ligand binds to a growth factor receptor and initiates growth signalling cascade
  • The EGFR/Her2 Receptor Family
    The EGFR/Her2 Receptor Family
  • Signal Transduction: BIBW 2992 (Tovok™ ) irreversibly block the growth factor receptor
    Signal Transduction: BIBW 2992 (Tovok™ ) irreversibly block the growth factor receptor
  • Laboratory work in Research and Development
    Laboratory work in Research and Development
  • R&D Laboratory Work
    R&D Laboratory Work

Media Contact

  • Boehringer Ingelheim GmbH
    Julia Meyer-Kleinmann
    Science & Technology Communications
    55216 Ingelheim am Rhein
    Germany
     
    Phone +49 / 6132 / 77 8271
    Fax +49 / 6132 / 77 66 01
    Contact

RSS feeds allow you to receive latest news and information about Boehringer Ingelheim.

Subscribe to RSS Feed